MyAverix Finance
ST · Healthcare
2cureX AB (2CUREX)
Biotechnology
2cureX AB (2CUREX) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $46.89M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2CUREX
2cureX AB (2CUREX) — FAQ
What is 2cureX AB's market cap?
2cureX AB (2CUREX) has a reported market cap of $46.89M (data as of 2026-05-24).
What is 2CUREX's P/E ratio?
The price-to-earnings (P/E) ratio for 2cureX AB (2CUREX) is 25.00 (data as of 2026-05-24).
Does 2cureX AB pay a dividend?
Dividend yield is not available in the current snapshot for 2cureX AB (2CUREX). Check the MyAverix Finance app for the latest dividend data.
What sector is 2cureX AB in?
2cureX AB (2CUREX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2CUREX listed on?
2CUREX is listed on ST.
What is 2cureX AB's net margin?
2cureX AB (2CUREX) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.